Upcoming Events.


September 26th 2023 - September 28th 2023

2023 Cantor Global Healthcare Conference

New York, NY, USA

October 20th 2023 - October 24th 2023

ESMO Congress 2023

Madrid, Spain

October 24th 2023

Annual General Meeting 2023

Immutep Annual General Meeting 2023 will be taking place at Offices of Piper Alderman, Governor Macquarie Tower, 1 Farrer Place, Sydney, NSW 2000 on Tuesday, 24 October 2023 at 10.30 am (AEDT)

Notice of Meeting

October 25th 2023 - October 27th 2023

Wilsons Drug and Device Healthcare Conference

Noosa, Australia

November 1st 2023 - November 5th 2023

SITC 2023

San Diego, CA, USA

November 1st 2023 - November 3rd 2023

AusBiotech 2023

Brisbane, Australia

November 14th 2023 - November 15th 2023

Targets & Cell Types in Immuno-Oncology Europe 2023

Berlin, Germany

Past Events.


September 12th 2023 - September 13th 2023

2023 Baird Global Healthcare Conference

New York, NY, USA

September 12th 2023 - September 13th 2023

Bell Potter's Emerging Leaders Conference 2023

September 12th 2023 - September 13th 2023

E&P Small Cap Healthcare Conference

Sydney, NSW, Australia

September 6th 2023 - September 7th 2023

Citi's 2023 18th Annual BioPharma Conference

Boston, MA, USA

August 7th 2023 - August 8th 2023

BTIG Virtual Biotechnology Conference 2023

June 23rd 2023

ShareCafe Hidden Gems Webinar

Marc Voigt, CEO of Immutep will participate in the upcoming virtual event to be held Friday 23rd of June 2023 from 12:30pm AEST / 10:30am AWST.

June 20th 2023

Maxim Healthcare Virtual Conference

June 8th 2023

Jefferies Healthcare Conference

New York, NY, USA

Link to Webcast

June 5th 2023 - June 8th 2023

2023 BIO International Convention

Boston, MA, USA

June 2nd 2023 - June 6th 2023

ASCO 2023 Annual Meeting

McCormick Place, Chicago, IL, USA and Online

May 16th 2023 - May 17th 2023

BIONNALE 2023

Berlin, Germany

May 16th 2023

JMP Securities Life Sciences Conference

New York, NY, USA

May 11th 2023 - May 13th 2023

ESMO Breast Cancer 2023

Berlin, Germany

May 9th 2023

KOL Event hosted by Ladenburg Thalmann & Co, Inc.

Deep Dive into Efti Development in NSCLC and HNSCC Landscapes discussion led by Ahu Demir, Ph.D., and featuring Martin Forster, M.D., Ph.D., of the University College London Cancer Institute and UCL Hospital NHS Foundation, and Wade T. Iams, M.D., MSCI, Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center Division of Hematology/Oncology.

Link to KOL Event webinar

March 29th 2023 - April 1st 2023

European Lung Cancer Congress 2023

Copenhagen, Denmark

March 20th 2023 - March 22nd 2023

BIO-EUROPE SPRING

Basel, Switzerland

February 17th 2023

ShareCafe Webinar

Marc Voigt, CEO of Immutep will participate in the upcoming virtual event and will deliver a presentation.

Speaking time of Marc Voigt: 12:30 pm AEDT on Friday, 17 February 2023

Link to the Presentation

January 9th 2023 - January 12th 2023

J.P. Morgan 41st Annual Healthcare Conference

Marc Voigt, CEO and Deanne Miller, COO will be attending and hosting meetings at the 41st Annual J.P. Morgan Healthcare Conference taking place January 9-12, 2023 at the Westin St. Francis in San Francisco, CA. 

December 5th 2022 - December 6th 2022

The JMP Securities Hematology and Oncology Summit

Marc Voigt, CEO of Immutep will participate in the event virtually and will deliver a corporate presentation.

Speaking time of Marc Voigt: 11:20 AM ET on Wednesday, 7 December 2022

Link to the webcast

November 23rd 2022

Annual General Meeting 2022

Immutep Annual General Meeting 2022 will be taking place at Offices of Piper Alderman, Governor Macquarie Tower, 1 Farrer Place, Sydney, NSW on Wednesday, 23 November 2022, 11.00 am (AEDT)

Notice of Meeting

November 14th 2022 - November 16th 2022

13th Annual Jefferies London Healthcare Conference

Marc Voigt, CEO of Immutep will participate in the upcoming in-person conference

Speaking time of Marc Voigt: 1:30pm - 2.00pm (UTC) on Thursday, 17 November 2022

A replay of the webcast is available here

For questions, please email londonhealthcareconf@jefferies.com 

November 8th 2022 - November 12th 2022

SITC - 37th Annual Meeting & Pre-Conference Programs 2022

The company will participate in the upcoming in-person conference.

Venue: Boston, MA

https://ascopost.com/videos/sitc-2022/wade-iams-on-nsclc-combining-an-antigen-presenting-cell-activator-with-pembrolizumab/

November 7th 2022 - November 9th 2022

Bell Potter Healthcare Conference 2022

Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the upcoming virtual conference and will deliver a presentation.

Speaking time of Marc Voigt: 10:00am - 10:30am (AEDT) on Wednesday, 9 November 2022 

September 29th 2022

Ladenburg Thalmann's 2022 Healthcare Conference

Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the upcoming conference to present a corporate overview

Link to Webcast

September 28th 2022

Cantor Oncology, Hematology & HemeOnc Conference

Marc Voigt, CEO and Deanne Miller, COO will participate in the in-person conference 

September 20th 2022 - September 22nd 2022

Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit

Immutep will participate in the 2nd Non-Small Cell Lung Cancer Drug Development Summit

Frédéric Triebel, CSO & CMO of Immutep speaks on the subject:

A Soluble LAG-3 Protein (Eftilagimod Alpha) with an Anti-PD-1 Antibody (Pembrolizumab): Results of a Phase II Study in NSCLC

Speaking time of Frederic Triebel: 12.00 EST, Thursday 22nd September 2022

Click here for the Presentation

Click here for the Event Guide